Treatment of Gemcitabine-Induced Thrombotic Microangiopathy Followed by Gemcitabine Rechallenge With Eculizumab
Kidney Int Rep
.
2021 Mar 6;6(5):1464-1468.
doi: 10.1016/j.ekir.2021.03.001.
eCollection 2021 May.
Authors
Orhan Efe
1
,
Lipika Goyal
2
,
Aralee Galway
2
,
Andrew X Zhu
2
,
John L Niles
1
,
Reza Zonozi
1
Affiliations
1
Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
2
Division of Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
PMID:
34013127
PMCID:
PMC8116759
DOI:
10.1016/j.ekir.2021.03.001
No abstract available
Publication types
Case Reports